Significant Growth Opportunities of Stem Cell Assay Market - Global Forecast to 2023

Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2023
“The global stem cell assay market is expected to reach USD 1,978.7 Million by 2023 from USD 791.9 Million in 2018, at a CAGR of 20.1%. “


The market growth is primarily driven by increasing government and private funding for stem cell research and technological innovations in stem cell research-based instruments.
The key players in the stem cell assay market include Merck (Germany), Thermo Fisher Scientific (US), GE Healthcare (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Promega Corporation (US), Cell Biolabs (US), PerkinElmer (US), Miltenyi Biotec (Germany), HemoGenix (US), Bio-Techne Corporation (US), STEMCELL Technologies (Canada), and Cellular Dynamics International (US).

Target Audience for this Report:

  • Manufacturers and vendors of stem cell assays
  • Research associations involved in stem cell research
  • Various research and consulting firms
  • Distributors of stem cell assays
  • Contract research manufacturers of stem cell assays
  • Healthcare institutions
  • Research institutes

Scope of the Report:

This report categorizes the stem cell assay market into the following segments:
Stem Cell Assay Market, By Type
  • Viability/Cytotoxicity
  • Isolation & Purification
  • Cell Identification
  • Proliferation
  • Differentiation
  • Function
  • Apoptosis
Stem Cell Assay Market, By Cell Type
  • Adult Stem CellsMesenchymal stem cells (MSCs)Induced pluripotent stem cells (iPSCs)Hematopoietic stem cells (HSCs)Umbilical cord stem cellsNeural stem cells (NSCs)
  • Human embryonic stem cells (hESCs)
Stem Cell Assay Market, By Product & Service
  • InstrumentsFlow CytometersMicroelectrode ArraysCell Imaging SystemsAutomated Cell Counters
  • Kits
  • Services
Stem Cell Assay Market, By Application
  • Regenerative Medicine & Therapy DevelopmentOrthopedic & Musculoskeletal Spine ApplicationsDermatologyCardiovascular ApplicationsCentral Nervous System ApplicationsOncologyDiabetesOther Applications
  • Drug Discovery & Development
  • Clinical Research
Stem Cell Assay Market, By End User
  • Biopharmaceutical & Biotechnology Companies
  • Research Institutes

To Know More @ https://www.marketsandmarkets.com/Market-Reports/stem-cell-assay-market-47610330.html

Comments

Post a Comment

Popular posts from this blog

Top Key Players in the Antimicrobial Susceptibility Testing Market

Dickinson and Company (US) , bioMérieux (France) and Becton are the Key Players in the Antimicrobial Susceptibility Testing Market. Factors such as rising prevelance of infectious diseases, emergence of multidrug-resistance are driving the growth of the antimicrobial susceptibility testing market.  Furthermore, technological advancements in rapid antimicrobial susceptibility testing methods and increased funding, research grants and public-private investmants are further increasing the demand for antimicrobial susceptibility testing products, thereby driving the growth of the market. "The global antimicrobial susceptibility testing market is expected to grow at a CAGR of 5.1% between 2017 and 2022." Becton, Dickinson and Company (US) held the second position in the antimicrobial susceptibility testing market in 2016.  The company operates through two business segments, namely, BD Medical (Medication and Procedural Solutions, Medication Management Solutions, Dia...
Read more